RIMAN's Parent Company Announces Sponsored Research Agreement to Advance Araliadiol Using Organ-on-a-Chip Technology

by | PRNewswire Asia

SEOUL, South Korea, April 15, 2026 /PRNewswire/ — ASK Company, the parent company of RIMAN, has entered into a sponsored research agreement with Mitragotri Laboratory at the Harvard John A. Paulson School of Engineering and Applied Sciences to validate the...

Reach Surgical Receives CE Mark Approval for iREACH IRIS, First Powered Reusable Stapler with Real-Time Firing Curve™ and 90° Articulation

by | PRNewswire Asia

-iREACH IRIS provides real-time, location-specific insight into tissue behaviour along the staple line SINGAPORE, April 15, 2026 /PRNewswire/ — Reach Surgical, the surgical solutions division of Genesis MedTech, has received CE Mark approval for iREACH IRIS, a...

Overload of technology and data overwhelming Singapore residents and their wellness journey: AIA Live Better Study

by | PRNewswire Asia

AIA Singapore’s latest Live Better Study reveals the double-edged sword of digital tools when it comes to wellness management, uncovering the growing tension between their benefits and the challenges of managing information overload and multiple platforms....

Mexican company Farmacias Similares brings Dr. Simi to Tokyo in Japan debut

by | PRNewswire Asia

A pop-up store is being opened by Farmacias Similares in Shibuya, which is in the heart of Tokyo. TOKYO, April 15, 2026 /PRNewswire/ — Dressed as a samurai and with his trademark energetic attitude, Dr. Simi—the face of Farmacias Similares— greets...

Ofood Kimchi Ramyun Surpasses 1 Million Units Sold in Canada

by | PRNewswire Asia

– Real Jongga Kimchi differentiation drives strong Gen Z response at Costco and Loblaws – FreshCo expansion to reach 150 stores nationwide in Canada in the second half of the year SEOUL, South Korea, April 14, 2026 /PRNewswire/ — Kimchi...

Senhwa Biosciences Secures Strategic Backing from Global Investor GEM with Up to NT$500 Million to Accelerate AI-Driven Drug Development

by | PRNewswire Asia

TAIPEI and SAN DIEGO, April 14, 2026 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company announced today the signing of a Memorandum of Understanding (MOU) with GEM YIELD BAHAMAS LIMITED, an affiliate of the global...